164 related articles for article (PubMed ID: 25804766)
1. Second cancers in chronic lymphocytic leukemia: growing importance in the era of improved treatment outcomes.
Langerbeins P; Maurer C; Cramer P; Eichhorst B; Hallek M
Leuk Lymphoma; 2015 Jun; 56(6):1575-6. PubMed ID: 25804766
[No Abstract] [Full Text] [Related]
2. Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.
Benjamini O; Jain P; Trinh L; Qiao W; Strom SS; Lerner S; Wang X; Burger J; Ferrajoli A; Kantarjian H; O'Brien S; Wierda W; Estrov Z; Keating M
Leuk Lymphoma; 2015 Jun; 56(6):1643-50. PubMed ID: 25308294
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
4. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
[No Abstract] [Full Text] [Related]
5. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
[No Abstract] [Full Text] [Related]
7. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Ballen KK; Antin JH
Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
[TBL] [Abstract][Full Text] [Related]
8. Therapy-related myelodysplastic syndrome or acute myelogenous leukemia in patients with acute promyelocytic leukemia (APL).
Garcia-Manero G; Kantarjian HM; Kornblau S; Estey E
Leukemia; 2002 Sep; 16(9):1888. PubMed ID: 12200720
[No Abstract] [Full Text] [Related]
9. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
10. Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.
Coorens THH; Collord G; Lu W; Mitchell E; Ijaz J; Roberts T; Oliver TRW; Burke GAA; Gattens M; Dickens E; Nangalia J; Tischkowitz M; Anderson J; Shlien A; Godfrey AL; Murray MJ; Behjati S
Blood; 2021 May; 137(21):2992-2997. PubMed ID: 33598691
[No Abstract] [Full Text] [Related]
11. Therapy-related myelodysplasia and fludarabine combination therapy - do the benefits justify the risk?
Carney DA; Seymour JF
Leuk Lymphoma; 2010 Nov; 51(11):1957-9. PubMed ID: 20858101
[No Abstract] [Full Text] [Related]
12. Long-term complications of cancer chemotherapy.
Pedersen-Bjergaard J
J Clin Oncol; 1995 Jul; 13(7):1534-6. PubMed ID: 7602341
[No Abstract] [Full Text] [Related]
13. Therapy-related acute myelogenous leukemia and myelodysplastic syndrome.
Borthakur G; Estey AE
Curr Oncol Rep; 2007 Sep; 9(5):373-7. PubMed ID: 17706165
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome/acute myelogenous leukaemia after adjuvant chemotherapy with pyrimidine anti-metabolites in three patients.
Pitini V; Arrigo C; Aloi G; Righi M; Falduto M; Teti D
Haematologica; 2001 Oct; 86(10):E30. PubMed ID: 11602437
[No Abstract] [Full Text] [Related]
16. Secondary myelodysplasia and acute leukemia following carboplatin-containing combination chemotherapy for ovarian cancer.
Colon-Otero G; Malkasian GD; Edmonson JH
J Natl Cancer Inst; 1993 Nov; 85(22):1858-60. PubMed ID: 8230267
[No Abstract] [Full Text] [Related]
17. Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents.
Randi ML; Fabris F; Girolami A
Haematologica; 1999 Nov; 84(11):1049-50. PubMed ID: 10553169
[No Abstract] [Full Text] [Related]
18. Therapy-related MDS and AML in acute promyelocytic leukemia.
Andersen MK; Pedersen-Bjergaard J
Blood; 2002 Sep; 100(5):1928-9; author reply 1929. PubMed ID: 12211197
[No Abstract] [Full Text] [Related]
19. Occurrence of myelodysplasia/acute myeloid leukemia 'on therapy' in two patients with acute promyelocytic leukemia.
Chelghoum Y; Plesa A; Ducastelle S; Elhamri M; Thomas X
Indian J Cancer; 2016; 53(1):59-60. PubMed ID: 27146742
[No Abstract] [Full Text] [Related]
20. High incidence of therapy-related myelodysplasia and acute leukaemia in general haematology clinic patients treated with fludarabine and cyclophosphamide for indolent lymphoproliferative disorders.
Bowcock SJ; Rassam SM; Lim Z; Ward SM; Ryali MM; Mufti GJ
Br J Haematol; 2006 Jul; 134(2):242-3. PubMed ID: 16846486
[No Abstract] [Full Text] [Related]
[Next] [New Search]
